Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prospects for new and effective antimalarial treatments have improved significantly in the past few years. There are more funds, new operational paradigms and actors, and more products in the pipeline. However, the limited novelty of the products currently in clinical development means that more emphasis therefore needs to be placed on the discovery of novel chemical entities to achieve effective, sustainable control. The development and deployment of new products is both lengthy and complex.

Type

Journal article

Journal

Bulletin de l'Academie nationale de medecine

Publication Date

10/2007

Volume

191

Pages

1285 - 1292

Addresses

olliarop@who.int

Keywords

Humans, Malaria, Sesquiterpenes, Artemisinins, Lactones, Antimalarials, Drug Therapy, Combination, Drug Evaluation, Preclinical, Drug Design, Forecasting, Adult, Child, Research Support as Topic